IBOV 166,302.02 ▼ 0.74% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL5.95▲ 1.20% USD/MXN19.08▲ 1.19% USD/CLP1,015▲ 0.68% USD/COP3,416▲ 3.30% USD/PEN3.45▲ 0.38% USD/ARS1,565▲ 0.34% USD/UYU40.61▲ 3.19% USD/PYG6,212▲ 2.85% USD/BOB11.64▲ 3.02% USD/DOP59.94▼ 0.43% USD/CRC441.73▲ 2.49% USD/GTQ7.64▲ 3.23% USD/HNL26.89▼ 0.14% USD/NIO36.62▲ 0.26% USD/VES913.46▼ 0.35% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.52▲ 2.37% USD/TTD6.70▲ 2.24% EUR/BRL6.53▲ 2.88% BRENT 89.67 ▼ 2.48% WTI 82.87 ▼ 0.47% IRON ORE 161.91 — — COPPER 5.62 ▼ 0.69% GOLD 3,672 ▼ 1.87% SILVER 44.01 ▼ 2.21% SOY 1,207 ▼ 0.78% CORN 452.75 ▲ 3.96% WHEAT 595.25 ▲ 4.43% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.35 ▼ 2.20% PETR4 42.77 ▼ 0.93% VALE3 58.61 ▼ 0.66% ITUB4 40.03 ▼ 0.40% BBDC4 13.87 ▼ 1.49% ABEV3 16.00 ▼ 0.44% BBAS3 14.14 ▲ 0.14% B3SA3 14.25 ▼ 0.35% WEGE3 50.68 ▼ 1.36% PRIO3 60.14 ▼ 2.80% SUZB3 55.25 ▼ 0.63% RENT3 29.01 ▼ 1.49% AZZA3 14.74 ▼ 6.59% CSAN3 3.08 ▼ 1.60% RAIZ4 16.80 ▼ 9.14% PCAR3 3.17 ▲ 6.02% GMAT3 4.13 ▲ 1.98% PSSA3 43.94 ▼ 1.61% CVCB3 0.73 ▼ 6.41% POSI3 3.37 ▲ 6.31% SLCE3 17.55 ▼ 1.85% NATU3 4.52 ▼ 5.44% BRKM5 2.63 — 0.00% RANI3 7.97 ▼ 1.24% IBOV 166,302.02 ▼ 0.74% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL 5.95 ▲ 1.16% USD/MXN 19.08 ▲ 1.16% USD/CLP 1,015 ▲ 0.66% USD/COP 3,416 ▲ 3.30% USD/PEN 3.45 ▲ 0.38% USD/ARS 1,565 ▲ 0.34% USD/UYU 40.61 ▲ 3.19% USD/PYG 6,212 ▲ 2.85% USD/BOB 11.64 ▲ 3.02% USD/DOP 59.94 ▼ 0.43% USD/CRC 441.73 ▲ 2.49% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▼ 0.14% USD/NIO 36.62 ▲ 0.26% USD/VES 913.46 ▼ 0.35% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.52 ▲ 2.37% USD/TTD 6.70 ▲ 2.24% EUR/BRL 6.53 ▲ 2.88% BRENT 89.67 ▼ 2.48% WTI 82.87 ▼ 0.47% IRON ORE 161.91 — — COPPER 5.62 ▼ 0.69% GOLD 3,672 ▼ 1.87% SILVER 44.01 ▼ 2.21% SOY 1,207 ▼ 0.78% CORN 452.75 ▲ 3.96% WHEAT 595.25 ▲ 4.43% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.35 ▼ 2.20% PETR4 42.77 ▼ 0.93% VALE3 58.61 ▼ 0.66% ITUB4 40.03 ▼ 0.40% BBDC4 13.87 ▼ 1.49% ABEV3 16.00 ▼ 0.44% BBAS3 14.14 ▲ 0.14% B3SA3 14.25 ▼ 0.35% WEGE3 50.68 ▼ 1.36% PRIO3 60.14 ▼ 2.80% SUZB3 55.25 ▼ 0.63% RENT3 29.01 ▼ 1.49% AZZA3 14.74 ▼ 6.59% CSAN3 3.08 ▼ 1.60% RAIZ4 16.80 ▼ 9.14% PCAR3 3.17 ▲ 6.02% GMAT3 4.13 ▲ 1.98% PSSA3 43.94 ▼ 1.61% CVCB3 0.73 ▼ 6.41% POSI3 3.37 ▲ 6.31% SLCE3 17.55 ▼ 1.85% NATU3 4.52 ▼ 5.44% BRKM5 2.63 — 0.00% RANI3 7.97 ▼ 1.24%
since 2009
Thursday, November 19, 2026

Brazil Business - Brazil

Hapvida’s Adjusted Q2 Profit All but Vanishes as Medical Costs Climb

Revenue still edged higher and the group even added dental customers. Yet surging medical claims left almost nothing at the bottom line, and the reported result stayed in the red.

By · · 5 min read
Hapvida - the Hospital de Caridade Sao Joao de Deus in Laranjeiras, Brazil
Hapvida’s Adjusted Q2 Profit All but Vanishes as Medical Costs Climb.

Brazil · Business

Key Facts

  • —The profit Hapvida posted adjusted second-quarter net income of just R$12.5 million (about US$2.42 million), down 95.8% year-on-year.
  • —The comparison That is down from R$299.5 million (about US$58 million) in the same quarter a year earlier.
  • —The revenue Net revenue still rose 3.9% to about R$7.97 billion (roughly US$1.54 billion).
  • —The squeeze The cash medical-loss ratio climbed to 75.2%, up 1.3 percentage points from a year earlier.
  • —The core Adjusted EBITDA fell 44.3% to R$504.4 million (about US$97.7 million), a margin of 6.3%.

Revenue still edged higher and the group even added dental customers. Yet surging medical claims left almost nothing at the bottom line, and the reported result stayed in the red.

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Hapvida, one of Brazil’s largest integrated health insurers and hospital operators, saw its adjusted second-quarter profit shrink almost to nothing. The company still sold more coverage than a year ago.

But the cost of paying for its members’ care rose faster than the money coming in.

What Hapvida reported

Hapvida posted adjusted net income of R$12.5 million, about US$2.3 million, for the second quarter of 2026. That is a fall of 95.8% from the R$299.5 million it earned on the same basis a year earlier.

In other words, almost the entire bottom line evaporated even though the business itself kept growing.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Hegseth signs military pact with Venezuela”

Why the profit almost vanished

The drop was not caused by shrinking sales or a one-off charge that will simply go away next quarter. It came from the everyday cost of care rising faster than the premiums the company collects.

When a health insurer pays out more of every real it takes in. The sliver left as profit gets very thin, very fast.

Live Company IntelligenceHapvida Participações e Investimentos S.A. — the full investor dossierCompany overview and the latest Rio Times coverage.

The claims problem in plain terms

The clearest sign of the squeeze is a figure the industry calls the medical-loss ratio, or sinistralidade. It measures how much of each premium real is spent on members’ doctor visits, hospital stays and procedures.

Hapvida’s cash version of that ratio rose to 75.2%. Up 1.3 points from a year ago and 3 points from the prior quarter.

Two profit numbers, honestly explained

There are actually two profit figures here, and it helps to keep them apart. The R$12.5 million is the adjusted result, which strips out large non-cash accounting items.

On a reported basis the group posted a net loss of R$217.1 million. Close to the R$205.8 million loss a year earlier, largely because of amortisation tied to its big merger.

Revenue grew, so where is the pressure

Sales were not the problem, and that is what makes this quarter unusual. Net revenue rose 3.9% to roughly R$7.97 billion, about US$1.48 billion, a solid top line.

The trouble sits below that line, where rising claims and costs ate through almost all of the operating margin.

A softer core result

Adjusted EBITDA, a cleaner read on core profitability, fell 44.3% to R$504.4 million, about US$93 million. That left an adjusted EBITDA margin of just 6.3%, a slim cushion for a company of this size.

A margin that thin leaves little room to absorb any further jump in medical costs.

Members edging away

The company also lost a little ground on the size of its book of business. Health-plan members slipped to 8.668 million, down about 16,000 from the previous quarter.

Dental customers, by contrast, grew to 7.293 million, so the pressure was concentrated in the core health plans.

What Hapvida actually does

Hapvida is unusual because it both sells health plans and runs the hospitals and clinics that treat its members. That model, built up through a wave of deals including its merger with NotreDame Intermédica.

Is meant to keep costs under one roof. It gives the company more control over care, but it also means rising medical costs hit it from every direction at once.

Why medical costs keep rising

Health costs have been climbing across Brazil, driven by more frequent use of services and pricier treatments. An ageing membership and higher demand for procedures push the claims bill up year after year.

Insurers try to offset this by raising premiums, but those increases often arrive months after the costs have already landed.

What it means, and what to watch

For members, the near-term worry is that thin margins usually lead to firmer premium increases down the road. For investors, the number to follow is the medical-loss ratio, because that is where this quarter went wrong.

If Hapvida can pull that ratio back down while holding on to members, its profit line has plenty of room to recover.

Frequently Asked Questions

How much did Hapvida earn in Q2 2026?

Adjusted net income of just R$12.5 million (about US$2.42 million), down 95.8% from R$299.5 million a year earlier.

Why did Hapvida’s profit fall so sharply?

The cost of paying for members’ care rose faster than premiums. Its cash medical-loss ratio climbed to 75.2%, squeezing almost all of the profit out of the quarter.

Did Hapvida’s revenue also fall?

No. Net revenue actually rose 3.9% to about R$7.97 billion (roughly US$1.54 billion), so the problem was costs, not sales.

What does Hapvida do?

It is one of Brazil’s largest integrated health companies, selling health plans and running the hospitals and clinics that treat its members.

Sources: Reuters, Estadao/E-Investidor, O Povo, SpaceMoney; company results (Q2 2026).

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.